Turner syndrome: New insights from prenatal genomics and transcriptomics
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In some parts of the world, prenatal screening using analysis of circulating cell‐free (cf) DNA in the plasma of pregnant women has become part of routine prenatal care with limited professional guidelines and without significant input from the Turner syndrome community. In contrast to the very high positive predictive values (PPVs) achieved with cfDNA analysis for trisomy 21 (91% for high‐risk and 82% for low‐risk cases), the PPVs for monosomy X are much lower (~26%). This is because the maternal plasma sample contains both maternal cfDNA and placental DNA, which is a proxy for the fetal genome. Underlying biological mechanisms for false positive monosomy X screening results include confined placental mosaicism, co‐twin demise, and maternal mosaicism. Somatic loss of a single X chromosome in the mother is a natural phenomenon that occurs with aging; this could explain many of the false positive cfDNA results. There is also increased awareness of women who have constitutional mosaicism for 45, X who are fertile. It is important to recognize that a positive cfDNA screen for 45, X does not mean that the fetus has Turner syndrome. A follow‐up diagnostic test, either amniocentesis or neonatal karyotype/chromosome microarray, is recommended. Research studies on cell‐free mRNA in second trimester amniotic fluid, which is almost exclusively fetal, demonstrate consistent dysregulation of genes involved in the hematologic, immune, and neurologic systems. This suggests that some of the pathophysiology of Turner syndrome occurs early in fetal life and presents novel opportunities for consideration of antenatal treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407349 · Cited by 817
Russell, L. M., Strike, P., Browne, C. E., & Jacobs, P. A. (2007) · Cytogenetic and Genome Research · doi:10.1159/000098184 · Cited by 264
Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome
Massingham, L. J., Johnson, K. L., Scholl, T. M., Slonim, D. K., Wick, H. C., & Bianchi, D. W. (2014) · Human Genetics · doi:10.1007/s00439-014-1448-y · Cited by 52
Self-citationGruchy, N., Vialard, F., Blondeel, E., Le Meur, N., Joly‐Hélas, G., Chambon, P., Till, M., Herbaut‐Graux, M., Vigouroux‐Castera, A., Coussement, A., et al. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4439 · Cited by 29 · cited 1×
“In one large French cytogenetics database, 84% of 975 cases diagnosed with Turner syndrome were initially detected due to the presence of fetal sonographic abnormalities (Gruchy et al., 2014).”
Background
Cited by
Turner syndrome: mechanisms and management
Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K., & Andersen, N. H. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0224-4 · Cited by 347
The changing face of Turner syndrome
Gravholt, C. H., Viuff, M., Just, J., Sandahl, K., Brun, S., van der Velden, J., Andersen, N. H., & Skakkebaek, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac016 · Cited by 149
Age at and indication for diagnosis of Turner syndrome in the pediatric population
Swauger, S., Backeljauw, P., Hornung, L., Shafer, J., Casnellie, L., & Gutmark‐Little, I. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62459 · Cited by 27
“Importantly, currently available noninvasive prenatal testing (NIPT) is not recommended at present for routine diagnosis for TS given the low positive predictive value (Bianchi, 2019; Gravholt et al., 2017; Meck et al., 2015).”
BackgroundTurner syndrome in diverse populations
Kruszka, P., Addissie, Y. A., Tekendo‐Ngongang, C., Jones, K. L., Savage, S. K., Gupta, N., Sirisena, N. D., Dissanayake, V. H. W., Paththinige, C. S., Aravena, T., et al. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61461 · Cited by 27
“With the advent of noninvasive prenatal screening and possibly newborn screening in the future, more information on full phenotypic spectrum of TS will be available (Bianchi, 2019; Murdock et al., 2017).”
BackgroundDiscussing non‐invasive prenatal testing on Reddit: The benefits, the concerns, and the comradery
Marcon, A. R., Ravitsky, V., & Caulfield, T. (2021) · Prenatal Diagnosis · doi:10.1002/pd.5841 · Cited by 16
Bedei, I., Gehrke, T., Gloning, K., Meyer‐Wittkopf, M., Willner, D., Krapp, M., Scharf, A., Degenhardt, J., Heling, K., Kozlowski, P., et al. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6320 · Cited by 7
“Calculations for this study are not based on a fully screened population but extracted fromadatabase exclusively focused on cases with suspicion or diagnosis of Turner syndrome, limiting the ability to assess the PPV of cfDNA screening for SCA.”
BackgroundInfluential
Metadata
- Authors
- Bianchi, D. W.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2019-01-31
- Volume
- 181
- Issue
- 1
- Pages
- 29-33
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2898747759
- Cited by
- 37
- References
- 4
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.